Chest X-ray Does Not Predict the Risk of Endotracheal Intubation and Escalation of Treatment in COVID-19 Patients Requiring Noninvasive Respiratory Support.
Tommaso PettenuzzoChiara GiraudoGiulia FicheraMichele Della PaoleraMartina ToccoMichael WeberDavide GorgiSilvia CarlucciFederico LionelloSara LococoAnnalisa BoscoloAlessandro De CassaiLaura PasinMarco RossatoAndrea VianelloRoberto VettorNicolò SellaPaolo NavalesiPublished in: Journal of clinical medicine (2022)
Forms of noninvasive respiratory support (NIRS) have been widely used to avoid endotracheal intubation in patients with coronavirus disease-19 (COVID-19). However, inappropriate prolongation of NIRS may delay endotracheal intubation and worsen patient outcomes. The aim of this retrospective study was to assess whether the CARE score, a chest X-ray score previously validated in COVID-19 patients, may predict the need for endotracheal intubation and escalation of respiratory support in COVID-19 patients requiring NIRS. From December 2020 to May 2021, we included 142 patients receiving NIRS who had a first chest X-ray available at NIRS initiation and a second one after 48-72 h. In 94 (66%) patients, the level of respiratory support was increased, while endotracheal intubation was required in 83 (58%) patients. The CARE score at NIRS initiation was not predictive of the need for endotracheal intubation (odds ratio (OR) 1.01, 95% confidence interval (CI) 0.96-1.06) or escalation of treatment (OR 1.01, 95% CI 0.96-1.07). In conclusion, chest X-ray severity, as assessed by the CARE score, did not allow predicting endotracheal intubation or escalation of respiratory support in COVID-19 patients undergoing NIRS.
Keyphrases
- coronavirus disease
- cardiac arrest
- sars cov
- end stage renal disease
- healthcare
- high resolution
- patients undergoing
- chronic kidney disease
- ejection fraction
- palliative care
- newly diagnosed
- open label
- quality improvement
- peritoneal dialysis
- dual energy
- prognostic factors
- respiratory syndrome coronavirus
- randomized controlled trial
- pain management
- magnetic resonance
- magnetic resonance imaging
- affordable care act
- patient reported outcomes
- study protocol
- electron microscopy
- health insurance
- replacement therapy
- contrast enhanced
- patient reported